Teva chairman’s other drug firm buys startup that could compete with Teva
Like Teva, startup Inspiro offers an inhaler for treating asthma and chronic obstructive pulmonary disease.
In a move that raises a possible conflict of interest, biochemical drug company Opko Health announced over the weekend it is acquiring Israeli startup Inspiro. Opko is headed by the chairman of Teva Pharmaceutical Industries, Phillip Frost.
Like us on Facebook and get articles directly in your news feed